Hints and tips:
...Yet for all the notoriety, insider trading is not defined in US law....
...In the pharmaceuticals sector, the state engineered the merger between Sanofi and Aventis to create a new state champion rather than allow the Swiss Novartis to swallow up Aventis....
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
...In a research note on Monday, Cowen argued that a number of the large pharmaceutical groups, led by Eli Lilly, Sanofi-Aventis and Pfizer, would be worth more if they divested separable business units, which...
...Sanofi-Aventis has continued aggressively to acquire others, including ultimately winning support for the takeover of US group Genzyme after raising its bid above $20bn....
...Diabetes medications still make up about 17 per cent of Lilly’s $22bn revenues, but in recent years it has lost ground to rivals such as Merck and Sanofi-Aventis....
...Sanofi-Aventis stepped up its pursuit of Genzyme on Sunday, outlining publicly its interest in a takeover deal as it inched closer to making a hostile offer for the US biotech company....
...High factory automation has helped contain V-Zug’s costs, including a smart new computerised logistics centre opened this year. “Productivity is a key success factor for us,” Mr Buhofer says....
...Dehecq’s belated adieu Farewell Jean-François Dehecq, the man who built Sanofi-Aventis into a French-based pharmaceutical giant with global reach through bold acquisitions during the past four decades....
...Matrix Corporate Capital argued that the drugmaker would make a better takeover target for Sanofi-Aventis than Genzyme, its troubled US rival....
...GlaxoSmithKline faded 1.3 per cent to £11.72 on fears it might be drawn into a bidding war for Genzyme, the US biotech that has been targeted by Sanofi-Aventis....
...In pharmaceuticals, the government engineered the merger between Sanofi and Aventis to create a new champion rather than allow the Swiss Novartis to swallow it up....
...A study by a British medical journal reported that a blood-thinning pill developed by the company worked better than Plavix, a rival drug made by Sanofi-Aventis....
...The World Health Organisation on Monday said that leading vaccine producers including Novartis, GlaxoSmithKline and Sanofi-Aventis had requested “wild type virus” samples of the A (H1N1) virus....
...Then again, now that the Dutch group has flagged its interest in a takeover, Sanofi-Aventis and its rivals may come back with counter offers....
...Bernstein saw Bristol-Myers Squibb, GlaxoSmithKline and Sanofi Aventis among potential buyers of the franchise....
...His appointment comes as GlaxoSmithKline also seeks a new US head of operations, following the recent departure of Chris Viehbacher, who takes over as chief executive of Sanofi-Aventis of France at the start...
...at Panmure Gordon in London....
...Aventis.”...
...They got pretty bad under President Jacques Chirac, especially when his then economy minister Nicolas Sarkozy frustrated German designs on Alstom and engineered the Sanofi-Aventis pharmaceutical merger that...
...But such problems are not unique to Sanofi-Aventis....
...Swiss drugmaker Novartis gained 23.7 per cent to SFr59.50 while in France, Sanofi-Aventis climbed 17.2 per cent to €44.44. Germany’s BMW was boosted by an upgrade from Goldman Sachs....
...Mr Buffett also added to his positions in Ingersoll-Rand, a maker of refrigeration gear, and Sanofi Aventis, the French drugmaker....
...Sales of Plavix, co-marketed with Paris-based Sanofi-Aventis SA, gained 15 per cent to $1.44bn in the third quarter....
...and Sanofi-Aventis of France, the pharmaceuticals companies....
International Edition